News|Articles|December 4, 2013

LSNE Appoints New COO

LSNE appoints Shawn Cain as COO, a new position within the company.

Lyophilization Services of New England (LSNE), a New Hampshire based contract-manufacturing organization, has appointed Shawn Cain as COO, a new position within the company. Cain joined LSNE in 2012 as vice- president of sterile manufacturing. In his new role, Cain will be responsible for overseeing day-to-day operations and ensuring companywide alignment with the corporate goals. Cain will report to Matthew Halvorsen, president and CEO of LSNE. Cain's 28-year career includes experience in the pharmaceutical, biotech, and medical device industries. Cain has held management positions within operations at Organogenesis, Formatech, Arbios Systems, and Becton Dickinson.

Source: LSNE


Related to this article

Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.
white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.
Transitioning mRNA from R&D to GMP
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.